ongoing car-t trials in earlier lines of therapy in myeloma & strategies to improve efficacy
Published 1 year ago • 178 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:06
moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
2:03
car-t therapy in myeloma: moving into earlier lines and treating patients with unmet medical needs
-
3:33
myeloma uk car-t treatment in myeloma
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
4:04
the future of myeloma treatment and the possibility of cure
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
3:23
bringing car-t therapy in earlier lines of treatment in myeloma: karmma-3, cartitude-4 & cartitude-6
-
2:30
an update on the current status of car-t therapy in multiple myeloma
-
4:42
car-t for myeloma: ongoing trials
-
2:01
car-t updates in myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
2:00
tolerability of car-t therapies in clinical trials and in the real-world
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
3:27
car-t cells in myeloma
-
0:47
novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain
-
14:10
highlights in multiple myeloma: improving access to car-t therapy, novel targets & future outlooks
-
1:21
developing off-the-shelf car t-cells to treat multiple myeloma
-
2:14
future role of car-t in myeloma